AACR logo

Advertisement

Table of Contents

Inhibitors of carbohydrate processing: A new class of anticancer agents.

P E Goss, M A Baker, J P Carver and J W Dennis

Clin Cancer Res September 1 1995 1 (9) 935-944;
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer.

H Gabra, S P Langdon, J E Watson, R A Hawkins, B B Cohen, L Taylor, J Mackay, C M Steel, R C Leonard and J F Smyth

Clin Cancer Res September 1 1995 1 (9) 945-953;
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.

A F Sobrero, C Aschele, A P Guglielmi, A M Mori, L M Tixi, E A Bolli, R Rosso, S Mammoliti, G A Rollandi and S Bertoglio

Clin Cancer Res September 1 1995 1 (9) 955-960;
Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer.

M Toi, K Inada, S Hoshina, H Suzuki, S Kondo and T Tominaga

Clin Cancer Res September 1 1995 1 (9) 961-964;
Phase I clinical trial of serotherapy in patients with acute myeloid leukemia with an immunoglobulin M monoclonal antibody to CD15.

E D Ball, K Selvaggi, D Hurd, R Herzig, L Clark, V Malley, J Persichetti and M deMagelhaus-Silverman

Clin Cancer Res September 1 1995 1 (9) 965-972;
Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.

I Athanasiadis, M S Kies, M Miller, N Ganzenko, A Joob, M Marymont, A Rademaker and W J Gradishar

Clin Cancer Res September 1 1995 1 (9) 973-979;
Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.

S Y Sharp, P M Rogers and L R Kelland

Clin Cancer Res September 1 1995 1 (9) 981-989;
Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.

J L Fischel, M C Etienne, T Spector, P Formento, N Renée and G Milano

Clin Cancer Res September 1 1995 1 (9) 991-996;
Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.

G J Miller, G E Stapleton, T E Hedlund and K A Moffat

Clin Cancer Res September 1 1995 1 (9) 997-1003;
High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells.

P Huang, L E Robertson, S Wright and W Plunkett

Clin Cancer Res September 1 1995 1 (9) 1005-1013;
Recombinant F(ab') C242-Pseudomonas exotoxin, but not the whole antibody-based immunotoxin, causes regression of a human colorectal tumor xenograft.

W Debinski and I Pastan

Clin Cancer Res September 1 1995 1 (9) 1015-1022;
Characterization of B1(Fv)PE38 and B1(dsFv)PE38: single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice.

I Benhar and I Pastan

Clin Cancer Res September 1 1995 1 (9) 1023-1029;
Serum concentrations of hepatocyte growth factor in breast cancer patients.

T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto and T Tominaga

Clin Cancer Res September 1 1995 1 (9) 1031-1034;
Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.

A Ishihara, T Yoshida, H Tamaki and T Sakakura

Clin Cancer Res September 1 1995 1 (9) 1035-1041;
Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.

M V González, M F Pello, C López-Larrea, C Suárez, M J Menéndez and E Coto

Clin Cancer Res September 1 1995 1 (9) 1043-1049;
High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.

W Zhang, S M Kornblau, T Kobayashi, A Gambel, D Claxton and A B Deisseroth

Clin Cancer Res September 1 1995 1 (9) 1051-1057;
Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells.

A Bagnato, R Tecce, C Moretti, V Di Castro, D Spergel and K J Catt

Clin Cancer Res September 1 1995 1 (9) 1059-1066;
1994 forbeck cancer forum on cell cycle checkpoints.

L Hartwell

Clin Cancer Res September 1 1995 1 (9) 1067-1067;